Rocket Lab's 100th Electron Launch Puts Execution Under the Microscope
Published on 11/13/2026 at 08:10 | Editorial boerse-global.de
Rocket Lab has set November 14 at 18:30 NZDT for the 100th Electron mission, a milestone flight that will carry an Earth-observation satellite for Japan's iQPS. The round number is a convenient hook, but the more telling detail for investors is what it represents: a booked customer contract moving from the manifest into the sky.
That distinction — between announced missions and executed ones — has become the central test for the stock. Shares slipped 2.8% in the prior session, and were down another 2.2% as Berenberg raised its price target to $85 from $83 while reiterating a Buy rating. The analyst house argues the market is underestimating both demand for launches and the prices they command, noting that launch bookings are running at roughly seven times last year's pace and that Neutron missions are already contracted into the 2030s.
A Backlog Built for the Long Haul
The order book lends weight to that thesis. Rocket Lab reported a backlog of $3.57 billion on Monday, a foundation for future revenue that only gains meaning if the work is converted at healthy margins. Neutron's contracted manifest includes 16 missions at a base launch price of $70 million apiece — a figure that could lift the economics if execution costs don't swallow the premium.
Third-quarter 2026 results, also reported Monday, showed revenue of $267.834 million, up 73% year over year. The growth rate points to a rapidly expanding business base. Whether that expansion translates into durable earnings and cash generation is the question that will define the next several reports.
There is already one encouraging signal on that front. Operating cash flow turned positive at $7.2 million on a GAAP basis during the quarter. Yet the GAAP loss of $0.12 per share fell short of analyst expectations, leaving investors to weigh a improving cash picture against a still-unprofitable bottom line.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Two Timelines, One Company
Rocket Lab's reach extends well beyond launch. The two spacecraft built for NASA's ESCAPADE mission completed their Mars injection maneuvers on Tuesday, with arrival targeted for 2027. The progress speaks to the company's ability to manage a range of spaceflight tasks — provided the remaining mission steps go to plan.
It also highlights how differently the company's clocks run. An Electron launch is days away; an interplanetary mission stretches across years. Each demands its own milestones, and for valuation purposes what matters is which obligations have been met and which work still lies ahead.
The Margin Is the Message
Guidance for the fourth quarter of 2026 offers the next concrete checkpoint. Rocket Lab expects revenue of $270 million to $290 million — another record — alongside a GAAP gross margin of 34% to 36%. The company also projected an adjusted EBITDA loss of $14 million to $20 million, a reminder that robust demand has yet to translate into profitability.
The bull case gains substance if that margin range is hit while launch demand stays firm. The bear case sharpens if higher launch prices fail to flow through to results — if costs rise faster than the benefits of new contracts, revenue growth could prove less valuable to shareholders than the headline numbers suggest. First flight of Neutron, meanwhile, remains targeted for no earlier than 2027.
Sell-side conviction has held even as targets shift. Morgan Stanley confirmed its Overweight rating on Monday while trimming its price target to $103 from $105 — a modest recalibration that underscores how much of the story now rests on assumptions about converting bookings into profitable flights.
For all the attention paid to individual target changes, the real arbiter will be the connection between contract quality and earnings progress. Rocket Lab has several verifiable tasks in front of it: fly the iQPS mission as promised, keep the ESCAPADE spacecraft on course, and deliver on its margin forecast. Technical milestones and financial improvement arriving together would make the story considerably more convincing. Until then, the gap between a $3.57 billion backlog and a quarterly loss is where the debate lives.
Ad
Rocket Lab Stock: New Analysis - 13 November
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
